These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19275594)

  • 1. Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.
    Chiappini F; Teicher E; Saffroy R; Debuire B; Vittecoq D; Lemoine A
    Curr HIV Res; 2009 Mar; 7(2):244-53. PubMed ID: 19275594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between length variation in the DNA polymerase gamma gene CAG repeat and lactic acidosis or neuropathy during antiretroviral treatment.
    Chen X; Goudsmit J; van der Kuyl AC
    AIDS Res Hum Retroviruses; 2002 May; 18(8):531-4. PubMed ID: 12036482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery.
    Nasi M; Pinti M; Chiesa E; Fiore S; Manzini S; Del Giovane C; D'Amico R; Palai N; Campatelli C; Sabbatini F; Roccio M; Tibaldi C; Masuelli G; Mussini C; Ferrazzi E; d'Arminio Monforte A; Cossarizza A;
    Antivir Ther; 2011; 16(3):365-72. PubMed ID: 21555819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.
    van der Valk M; Gisolf EH; Reiss P; Wit FW; Japour A; Weverling GJ; Danner SA;
    AIDS; 2001 May; 15(7):847-55. PubMed ID: 11399957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
    Brinkman K; Smeitink JA; Romijn JA; Reiss P
    Lancet; 1999 Sep; 354(9184):1112-5. PubMed ID: 10509516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
    Chêne G; Amellal B; Pédrono G; Gourlain K; Rancinan C; Journot V; Cotte L; Palmer P; Castro ND; Calvez V; Molina JM;
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):54-61. PubMed ID: 17263633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
    Martin AM; Hammond E; Nolan D; Pace C; Den Boer M; Taylor L; Moore H; Martinez OP; Christiansen FT; Mallal S
    Am J Hum Genet; 2003 Mar; 72(3):549-60. PubMed ID: 12587093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
    Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
    AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside reverse transcriptase inhibitors induced hepatocellular mitochondrial DNA lesions and compensatory enhancement of mitochondrial function and DNA repair.
    Liang Q; Zeng J; Wu J; Qiao L; Chen Q; Chen D; Zhang Y
    Int J Antimicrob Agents; 2018 Mar; 51(3):385-392. PubMed ID: 28843815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.
    Koczor CA; Lewis W
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1493-504. PubMed ID: 20929279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
    Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
    Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
    Kohler JJ; Lewis W
    Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe toxicity and polymerase-γ gene abnormalities in Malawian adults on stavudine-based antiretroviral therapy.
    van Oosterhout JJ; Gardner K; Mallewa J; Kaunda S; Kampira E; Payne B; Heyderman RS; Chinnery P
    Pharmacogenet Genomics; 2013 Nov; 23(11):624-6. PubMed ID: 23962909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
    J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients.
    Long X; Wang X; Chen Y; Guo X; Zhou F; Fan Y; Ge N; Guo M; Zhang Z; Dong G
    Bull Cancer; 2017 Jun; 104(6):500-507. PubMed ID: 28457473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.
    Casula M; van der Valk M; Wit FW; Nievaard MA; Reiss P
    HIV Med; 2007 Jan; 8(1):32-7. PubMed ID: 17305930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
    Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
    J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.